ImageneBio, Inc.
IMA
$6.63
$0.426.76%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 547.27% | -38.11% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 261.38% | 8.30% | |||
| Operating Income | -261.38% | -22.75% | |||
| Income Before Tax | -227.66% | -24.81% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -226.68% | -24.81% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -226.68% | -24.81% | |||
| EBIT | -261.38% | -22.75% | |||
| EBITDA | -261.45% | -22.76% | |||
| EPS Basic | 60.48% | -38,303.54% | |||
| Normalized Basic EPS | 45.75% | -40,853.66% | |||
| EPS Diluted | 60.48% | -38,303.54% | |||
| Normalized Diluted EPS | 45.75% | -40,853.66% | |||
| Average Basic Shares Outstanding | 504.05% | -99.69% | |||
| Average Diluted Shares Outstanding | 504.05% | -99.69% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||